-+ 0.00%
-+ 0.00%
-+ 0.00%

SCIENTURE REPORTS Q3 2026 RESULTS WITH APPROXIMATELY 265% SEQUENTIAL REVENUE GROWTH DRIVEN BY THE COMMERCIAL LAUNCH OF REZENOPY™

Reuters·11/16/2026 13:30:02

Please log in to view news